Agape ATP Corporation filings document its public-company reporting, Nasdaq listing compliance, material agreements, shareholder votes, governance matters, and capital-structure activity. Recent Form 8-K reports cover Nasdaq continued-listing notices and regained compliance, entry into energy-sector collaboration agreements through ATPC Green Energy Sdn. Bhd., and annual meeting voting results.
The company's proxy materials describe director elections, auditor ratification, Nasdaq-related share issuance approval, and charter matters. Its reporting record also includes annual-report timing disclosure on Form 12b-25, together with recurring disclosures on operating and financial results, risk, governance, and securities matters.
Agape ATP Corporation reported Q1 2026 results with a smaller loss but continued financial strain. Revenue was $273,658, slightly below $289,037 a year earlier, while gross profit edged up to $159,409 as cost of revenue declined.
Operating expenses remained high at $836,781, leading to a loss from operations of $677,372. A large net exchange gain and marketable securities gains lifted total other income to $336,466, reducing net loss to $340,906 from $712,919. Cash was $220,779, but operating activities used $394,770 of cash.
The balance sheet shows total assets of $24.9M and equity of $22.1M, dominated by a $24.1M deposit with Bi Cheng Investment Management for future investments. Management states this investment is still unidentified and its financial return is uncertain, and discloses “substantial doubt” about the Company’s ability to continue as a going concern.
Agape ATP Corporation reports modest 2025 growth while highlighting significant operational and capital markets risks. Revenue rose about 15.2% to approximately $1.5 million, with gross profit up to roughly $0.8 million, driven by its Malaysian health and wellness network-marketing model and initial steps into renewable energy and digital wellness.
The company serves 56,465 distributors and 72,201 members, but relies heavily on a few Malaysian suppliers and has only 18 employees. Management discloses multiple material weaknesses in internal control over financial reporting, limited insurance coverage, concentrated supplier and regulatory risk, and exposure to shifting consumer preferences.
Agape also details substantial equity dilution: stockholders approved an increase in authorized common shares to 500 million and the issuance of 46 million new shares at $0.50 each. The report further warns that the company faces Nasdaq delisting risk due to a prolonged low share price and has already received Staff determinations requiring an appeal to maintain its listing.
Agape ATP Corporation notified the SEC it cannot timely file its Form 10-K for the year ended December 31, 2025 and expects to use the fifteen-day grace period under Rule 12b-25 to file. The delay is to obtain supporting documentation and allow the independent auditor to complete its audit.
The notification was signed by How Kok Choong on March 31, 2025. The company states this delay is due to additional time needed to complete audit procedures and collect documentation.
Agape ATP Corporation reported that Nasdaq has confirmed the company has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The company had previously received Nasdaq notices in January and February 2026 citing a bid price below $1.00 per share and a closing bid of $0.10 or less for ten consecutive trading days under the “Low Priced Stocks” rule.
Following the March 10, 2026 letter from the Nasdaq Hearings Advisor, the scheduled March 17, 2026 hearing has been cancelled, and the company’s common stock will continue trading on Nasdaq under the symbol ATPC.
Agape ATP Corporation, through its wholly owned subsidiary ATPC Green Energy Sdn. Bhd., has entered into a non-exclusive Collaboration Agreement with Citadel Investment LLC, a Dubai-based investment and global commodities trading firm, effective March 2026.
The parties plan to cooperate on the sale and purchase of oil, gas, refinery and petrochemical products by leveraging their respective commercial networks to identify, structure and facilitate cross-border energy transactions. The agreement outlines commission or profit-sharing for transactions introduced under the partnership and includes provisions on intellectual property, assignment, confidentiality, and protection of clients and business partners introduced by either party.
Agape ATP Corporation has filed a mixed shelf registration that allows it to offer and sell up to $200,000,000 of common stock, preferred stock, warrants and units over time. Actual terms, prices and amounts for each sale will be set in future prospectus supplements.
The company plans to use any proceeds for general corporate purposes, including marketing and e‑commerce for its health and wellness products, R&D and technology development, expansion into ASEAN and U.S. markets, strategic acquisitions in the wellness ecosystem, and working capital.
Agape operates primarily in Malaysia’s health and wellness sector through a direct-selling model, offering nutritional programs and complementary therapies, and is also developing renewable energy and digital wellness platforms. Its common stock trades on Nasdaq under the symbol ATPC.
Agape ATP Corporation is implementing a 1-for-50 reverse stock split of its issued and outstanding common stock. Shareholders approved an amendment allowing one or more reverse splits of up to 1-for-5,000, and the board has chosen a 1-for-50 ratio.
The reverse split is expected to become effective on February 9, 2026, with the common stock trading on a split-adjusted basis on the Nasdaq Capital Market beginning February 10, 2026, under the same symbol “ATPC.” No fractional shares will be issued; any fraction will be rounded up to the nearest whole share, and the authorised common share count will remain unchanged.
Following the reverse split, the common stock will receive a new CUSIP number, 008389306, and outstanding equity awards will be proportionately adjusted for both share amounts and exercise prices.
Agape ATP Corporation has received a determination from Nasdaq staff to delist its securities after a prolonged share price decline. The decision follows an earlier notice that the company failed to meet Nasdaq’s minimum bid price requirement of $1.00 per share.
Nasdaq staff cited that, as of January 30, 2026, Agape ATP’s securities had a closing bid of $0.10 or less for ten consecutive trading days, triggering Nasdaq’s Low Priced Stocks rule. The company plans to request a hearing by February 9, 2026, which will temporarily prevent suspension and a Form 25-NSE filing while a panel reviews the case.
Agape ATP Corporation held its Annual Meeting of Stockholders on January 30, 2026, where all matters submitted to a vote were approved. One key proposal received 30,095,479 votes for, 50 against and 421 abstentions, indicating near-unanimous support.
Stockholders also elected directors including How Kok Choong, who received 29,562,792 votes for, 2,898 withheld votes and 421 abstentions, with similar strong support levels for the other board nominees.
Agape ATP Corporation reported that Nasdaq has notified the company it no longer meets the continued listing requirement to maintain a minimum bid price of $1 per share under Nasdaq Listing Rule 5550(a)(2). The notice is based on closing bid prices from December 10, 2025 to January 26, 2026.
The company has 180 calendar days, until July 27, 2026, to regain compliance. If it meets other Nasdaq Capital Market listing standards, it may qualify for an additional 180‑day period and could use measures such as a reverse stock split. Failing to regain compliance could lead to delisting. Agape ATP is evaluating options and intends to regain compliance, but there is no assurance it will succeed.